203 related articles for article (PubMed ID: 35554594)
1. Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1.
van der Hoeven AE; Fronczek R; Schinkelshoek MS; Roelandse FWC; Bakker JA; Overeem S; Bijlenga D; Lammers GJ
Sleep; 2022 May; 45(5):. PubMed ID: 35554594
[TBL] [Abstract][Full Text] [Related]
2. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
[TBL] [Abstract][Full Text] [Related]
3. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
[TBL] [Abstract][Full Text] [Related]
4. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
5. Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.
Andlauer O; Moore H; Jouhier L; Drake C; Peppard PE; Han F; Hong SC; Poli F; Plazzi G; O'Hara R; Haffen E; Roth T; Young T; Mignot E
JAMA Neurol; 2013 Jul; 70(7):891-902. PubMed ID: 23649748
[TBL] [Abstract][Full Text] [Related]
6. Rapid eye movement sleep duration during the multiple sleep latency test to diagnose hypocretin-deficient narcolepsy.
Lopez R; Barateau L; Laura Rassu A; Evangelista E; Chenini S; Scholz S; Jaussent I; Dauvilliers Y
Sleep; 2023 Jan; 46(1):. PubMed ID: 36222741
[TBL] [Abstract][Full Text] [Related]
7. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.
Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E
Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989
[TBL] [Abstract][Full Text] [Related]
8. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.
Nishino S; Sakurai E; Nevsimalova S; Yoshida Y; Watanabe T; Yanai K; Mignot E
Sleep; 2009 Feb; 32(2):175-80. PubMed ID: 19238804
[TBL] [Abstract][Full Text] [Related]
9. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
Kanbayashi T; Kodama T; Kondo H; Satoh S; Inoue Y; Chiba S; Shimizu T; Nishino S
Sleep; 2009 Feb; 32(2):181-7. PubMed ID: 19238805
[TBL] [Abstract][Full Text] [Related]
10. Utility of measuring CSF hypocretin-1 level in patients with suspected narcolepsy.
Gabryelska A; Szmyd B; Maschauer EL; Roguski A; Canham R; Morrison I; Białasiewicz P; Riha RL
Sleep Med; 2020 Jul; 71():48-51. PubMed ID: 32492554
[TBL] [Abstract][Full Text] [Related]
11. Narcolepsy with intermediate cerebrospinal level of hypocretin-1.
Postiglione E; Barateau L; Pizza F; Lopez R; Antelmi E; Rassu AL; Vandi S; Chenini S; Mignot E; Dauvilliers Y; Plazzi G
Sleep; 2022 Feb; 45(2):. PubMed ID: 34902030
[TBL] [Abstract][Full Text] [Related]
12. Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin: An Explanation?
Drakatos P; Leschziner G
J Clin Sleep Med; 2016 Mar; 12(3):449-50. PubMed ID: 26564387
[TBL] [Abstract][Full Text] [Related]
13. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
14. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy.
Lopez R; Barateau L; Evangelista E; Chenini S; Robert P; Jaussent I; Dauvilliers Y
Sleep; 2017 Jan; 40(1):. PubMed ID: 28364477
[TBL] [Abstract][Full Text] [Related]
15. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
[TBL] [Abstract][Full Text] [Related]
16. Progressive narcolepsy: how to deal with intermediate hypocretin-1 values?
Ricordeau F; Bridoux A; Raverot V; Peter-Derex L
J Clin Sleep Med; 2023 Jul; 19(7):1375-1378. PubMed ID: 37066739
[TBL] [Abstract][Full Text] [Related]
17. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S
Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400
[TBL] [Abstract][Full Text] [Related]
18. Repeated polysomnography and multiple sleep latency test in narcolepsy type 1 and other hypersomnolence disorders.
Torstensen EW; Haubjerg Østerby NC; Kornum BR; Wanscher B; Mignot E; Barløse M; Jennum PJ
Sleep Med; 2023 Oct; 110():91-98. PubMed ID: 37544279
[TBL] [Abstract][Full Text] [Related]
19. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality.
Ruoff C; Rye D
Curr Med Res Opin; 2016 Oct; 32(10):1611-1622. PubMed ID: 27359185
[TBL] [Abstract][Full Text] [Related]
20. Traditional biomarkers in narcolepsy: experience of a Brazilian sleep centre.
Coelho FM; Pradella-Hallinan M; Pedrazzoli M; Soares CA; Fernandes GB; Gonçalves AL; Tufik S; Bittencourt LR
Arq Neuropsiquiatr; 2010 Oct; 68(5):712-5. PubMed ID: 21049180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
